发明名称 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERI
摘要 This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor or p56<lck> tyrosine kinase activity, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.
申请公布号 HU0002084(A3) 申请公布日期 2000.12.28
申请号 HU20000002084 申请日期 1998.05.28
申请人 AVENTIS PHARMACEUTICALS INC., COLLEGEVILLE, PENNSYLVANIA 发明人
分类号 A61K31/47;A61K31/495;A61K31/498;A61K31/5377;A61P9/00;A61P9/10;A61P17/06;A61P19/08;A61P29/00;A61P35/00;A61P35/02;A61P43/00;C07D215/20;C07D215/38;C07D241/42;C07D241/44;C07D241/52;C07D241/54;C07D403/04;C07D405/10;C07D405/12;C07D453/06 主分类号 A61K31/47
代理机构 代理人
主权项
地址